Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermategrity Relieve Cream is a topical over-the-counter (OTC) skincare product developed by Scotiaderm Inc. to provide relief from symptoms of Moisture-Associated Skin Damage (MASD) and general skin irritation. Formulated as a soothing natural product, it is designed to comfort skin affected by prolonged exposure to moisture, such as incontinence-associated dermatitis or chafing. The cream is part of the Dermategrity product line, which was founded by biochemist Dr. Ann Gordon to address severe skin breakdown. While specific active ingredients for the Relieve Cream are not explicitly detailed in primary sources, the product line is known to utilize protective barriers and potentially plant-based protease inhibitors to mitigate skin damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermategrity Relieve Cream.